<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="2bd614b6-02ce-49e3-86e2-dfaec7a13e04"/>
   <code code="34391-3" displayName="HUMAN PRESCRIPTION DRUG LABEL" codeSystem="2.16.840.1.113883.6.1"/>
   <title>
      <content styleCode="bold">These highlights do not include all the information needed to use <content styleCode="bold">CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION</content> safely and effectively. See full prescribing information for <content styleCode="bold">CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION</content>.<br/>
      </content>
      <br/>
      <content styleCode="bold">CALCIUM GLUCONATE in sodium chloride injection, for intravenous use <br/>
      </content>
      <content styleCode="bold">Initial U.S. Approval: 1941</content>
   </title>
   <effectiveTime value="20240418"/>
   <setId root="8ee79b4c-21d3-4742-ae37-e2f562917706"/>
   <versionNumber value="16"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="675474666" root="1.3.6.1.4.1.519.1"/>
            <name>Amneal Pharmaceuticals Private Limited</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="675474666" root="1.3.6.1.4.1.519.1"/>
                        <name>Amneal Pharmaceuticals Private Limited</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2362" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2363" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2362" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2363" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2362" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2363" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" displayName="pack" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2362" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" displayName="pack" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2363" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84382" displayName="sterilize" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2362" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84382" displayName="sterilize" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="80830-2363" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="6232251c-8196-4125-b2d9-feb9acb44e9d"/>
               <code code="48780-1" displayName="SPL listing data elements section" codeSystem="2.16.840.1.113883.6.1"/>
               <effectiveTime value="20240418"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="80830-2362" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>CALCIUM GLUCONATE</name>
                        <formCode code="C42945" displayName="INJECTION, SOLUTION" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>calcium gluconate</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="20"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="CZN0MI5R31" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CALCIUM GLUCONATE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="2M83C4R6ZB" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CALCIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="6AP9J91K4V" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CALCIUM SACCHARATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="50"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" displayName="BAG" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" displayName="POUCH" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                    <asContent>
                                       <quantity>
                                          <numerator unit="1" value="24"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="80830-2362-9" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43182" displayName="CARTON" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20230908"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="50"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" displayName="BAG" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" displayName="POUCH" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                    <asContent>
                                       <quantity>
                                          <numerator unit="1" value="12"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="80830-2362-2" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43182" displayName="CARTON" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20231108"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA217174" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" displayName="ANDA" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20230908"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" displayName="INTRAVENOUS" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="80830-2363" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>CALCIUM GLUCONATE</name>
                        <formCode code="C42945" displayName="INJECTION, SOLUTION" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>calcium gluconate</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="20"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="CZN0MI5R31" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CALCIUM GLUCONATE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="2M83C4R6ZB" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CALCIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="6AP9J91K4V" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CALCIUM SACCHARATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="100"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" displayName="BAG" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" displayName="POUCH" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                    <asContent>
                                       <quantity>
                                          <numerator unit="1" value="24"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="80830-2363-9" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43182" displayName="CARTON" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20230908"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="100"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43167" displayName="BAG" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code/>
                                    <formCode code="C43200" displayName="POUCH" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                    <asContent>
                                       <quantity>
                                          <numerator unit="1" value="12"/>
                                          <denominator value="1"/>
                                       </quantity>
                                       <containerPackagedProduct>
                                          <code code="80830-2363-2" codeSystem="2.16.840.1.113883.6.69"/>
                                          <formCode code="C43182" displayName="CARTON" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       </containerPackagedProduct>
                                       <subjectOf>
                                          <marketingAct>
                                             <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                             <statusCode code="active"/>
                                             <effectiveTime>
                                                <low value="20231108"/>
                                             </effectiveTime>
                                          </marketingAct>
                                       </subjectOf>
                                    </asContent>
                                 </containerPackagedProduct>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA217174" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" displayName="ANDA" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20230908"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" displayName="INTRAVENOUS" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="LINK_48a0e91b-f312-4b7b-8793-a4243b21b18a">
               <id root="53386408-34a6-44b0-b4a0-0e0a548d3aff"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Calcium gluconate in sodium chloride injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.</paragraph>
                  <paragraph>
                     <content styleCode="underline">Limitations of Use</content>
                  </paragraph>
                  <paragraph>The safety of calcium gluconate injection for long term use has not been established.</paragraph>
               </text>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Calcium gluconate in sodium chloride injection is a form of calcium indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. (<linkHtml href="#LINK_48a0e91b-f312-4b7b-8793-a4243b21b18a">1</linkHtml>) </item>
                        </list>
                        <list listType="unordered" styleCode="Disk">
                           <item> Limitations of Use: The safety of calcium gluconate injection for long term use has not been established. (<linkHtml href="#LINK_48a0e91b-f312-4b7b-8793-a4243b21b18a">1</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="LINK_1ac300b1-ede1-4e26-9636-5af2ec1aa9c9">
               <id root="4ff1fa96-f4a3-42a3-a1dd-2225dc7ab8c9"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <text/>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disk">
                           <item>Contains 20 mg of calcium gluconate per mL which contains 1.86 mg (0.093 mEq) of elemental calcium. (<linkHtml href="#LINK_3d0f251b-0ddb-43e6-b6e4-7ffc6a03c170">2.1</linkHtml>)</item>
                           <item>Administer intravenously (bolus or continuous infusion) via a secure intravenous line. (<linkHtml href="#LINK_3d0f251b-0ddb-43e6-b6e4-7ffc6a03c170">2.1</linkHtml>)</item>
                           <item>See Full Prescribing Information (FPI) for administration rates and appropriate monitoring. (<linkHtml href="#LINK_3d0f251b-0ddb-43e6-b6e4-7ffc6a03c170">2.1</linkHtml>)</item>
                           <item>Do not dilute calcium gluconate in sodium chloride injection prior to use. Any unused portion should be discarded. (<linkHtml href="#LINK_3d0f251b-0ddb-43e6-b6e4-7ffc6a03c170">2.1</linkHtml>)</item>
                           <item>Individualize the dose within the recommended range in adults and pediatric patients depending on the severity of symptoms of hypocalcemia, the serum calcium level and the acuity of onset of hypocalcemia. See Table 2 in the FPI for dosing recommendations in mg of calcium gluconate for neonates, pediatric and adult patients. (<linkHtml href="#LINK_5ad6f916-6130-408d-b286-236fc9019e56">2.2</linkHtml>)</item>
                           <item>Measure serum calcium during intermittent infusions every 4 hours to 6 hours and during continuous infusion every 1 hour to 4 hours. (<linkHtml href="#LINK_0649f771-be4c-4444-af7a-a85aae87d185">2.3</linkHtml>)</item>
                           <item>Calcium gluconate injection is not physically compatible with fluids containing phosphate or bicarbonate. Precipitation may result if mixed. See FPI for all drug incompatibilities. (<linkHtml href="#LINK_e464cfe0-f556-4613-9e68-bab58d845931">2.5</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="LINK_3d0f251b-0ddb-43e6-b6e4-7ffc6a03c170">
                     <id root="bc342e99-aeb9-4901-bdd5-f41542863160"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 Important
Administration Instructions</title>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Calcium gluconate in sodium chloride injection contains 20 mg of calcium gluconate per mL which contains 1.86 mg (i.e. 0.093 mEq) of elemental calcium. See Table 1 for amounts of elemental calcium in calcium gluconate in sodium chloride injection.</item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">Table 1: Amount of Calcium Gluconate and Elemental Calcium</content>
                        </paragraph>
                        <table width="100%" cellspacing="0" cellpadding="0" border="1">
                           <col width="17pt"/>
                           <col width="17pt"/>
                           <col width="17pt"/>
                           <col width="17pt"/>
                           <tbody>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Total Strength per Total Volume</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Strength per mL</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Total Amount of Elemental Calcium (mg) per Total Volume</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Total Amount of Elemental Calcium (mEq) per Total Volume</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>1,000 mg per 50 mL</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>20 mg/mL</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>93 mg per 50 mL</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>4.65 mEq per 50 mL</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>2,000 mg per 100 mL</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>20 mg/mL</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>186 mg per 100 mL</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>9.3 mEq per 100 mL</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <list listType="unordered" styleCode="Disc">
                           <item>Do not dilute calcium gluconate in sodium chloride injection prior to use. Any unused portion should be discarded <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_e464cfe0-f556-4613-9e68-bab58d845931">Dosage and Administration (2.5)</linkHtml>]. </content>
                           </item>
                           <item>Inspect calcium gluconate in sodium chloride injection visually prior to administration. The solution should appear clear and colorless. Do not administer if there is particulate matter or discoloration. </item>
                           <item>Administer calcium gluconate in sodium chloride injection intravenously via a secure intravenous line to avoid calcinosis cutis and tissue necrosis <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_33dd520c-48cc-4708-a942-e1a6380a77d4">Warnings and Precautions (5.3)</linkHtml>]</content>. </item>
                           <item>Administer calcium gluconate in sodium chloride injection by continuous infusion at the rate recommended in Table 2 <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_5ad6f916-6130-408d-b286-236fc9019e56">Dosage and Administration (2.2)</linkHtml>] </content>and monitor patients, vitals, calcium and ECG during the infusion <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_af37c4d0-ddac-4d03-9bec-a46a4ca7ac2c">Warnings and Precautions (5.4)</linkHtml>]</content>. </item>
                           <item>Check solution container composition, lot number and expiry date. </item>
                           <item>Do not admix with other drugs. </item>
                           <item>Do not use solution containers in series connections. <br/>
                           </item>
                           <item>The intact twist-off port cap provides visual tamper evidence. Do not use if twist-off port cap is prematurely removed. Maintain strict aseptic technique during handling.</item>
                        </list>
                        <paragraph>INSTRUCTIONS FOR USE</paragraph>
                        <list listType="ordered" styleCode="Arabic">
                           <item>Always inspect the solution container before and after removal from the overwrap. </item>
                           <item>Place the solution container on a clean, flat surface. Remove the solution container from the overwrap. </item>
                           <item>Check the solution container for leaks by squeezing firmly. If leaks are found, discard. </item>
                           <item>Do not use if the solution is cloudy or a precipitate is present.</item>
                        </list>
                        <paragraph>To Prepare for Administration</paragraph>
                        <list listType="ordered" styleCode="Arabic">
                           <item>Immediately before inserting the infusion set, remove twist-off port from the bag. </item>
                           <item>Use a non-vented infusion set or close the air-inlet on a vented set. </item>
                           <item>Close the roller clamp of the infusion set. </item>
                           <item>Hold the base of the infusion port and push spike until fully inserted. The infusion port is not intended to be spiked more than once. </item>
                           <item>Suspend solution container from hanger hole. </item>
                           <item>For single-dose only. Discard unused portion.</item>
                        </list>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_5ad6f916-6130-408d-b286-236fc9019e56">
                     <id root="edf057a0-550e-4f06-b246-4624fba79844"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2
Recommended Dosage</title>
                     <text>
                        <paragraph>Individualize the dose of calcium gluconate in sodium chloride injection within the recommended range depending on the severity of symptoms of hypocalcemia, the serum calcium level and the acuity of onset of hypocalcemia.</paragraph>
                        <paragraph>Table 2 provides dosing recommendations for calcium gluconate in sodium chloride injection in mg of calcium gluconate for neonates, pediatric and adult patients.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Table 2: Dosing Recommendations in mg of Calcium Gluconate for Neonate, Pediatric and Adult Patients</content>
                        </paragraph>
                        <table width="100%" cellspacing="0" cellpadding="0" border="1">
                           <col width="17pt"/>
                           <col width="17pt"/>
                           <col width="17pt"/>
                           <col/>
                           <tbody>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Patient Population</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Initial Dose</content>
                                    </paragraph>
                                 </td>
                                 <td colspan="2" styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Subsequent Doses (if needed)</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule"/>
                                 <td styleCode=" Botrule Toprule Lrule Rrule"/>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Bolus</content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Continuous Infusion</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Neonate (≤ </content>
                                       <content styleCode="bold">1 month) </content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>100 mg/kg to 200 mg/kg</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>100 mg/kg to 200 mg/kg every 6 hours</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>Initiate at 17 mg/kg/hour to 33 mg/kg/hour</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Pediatric (&gt; 1 month to &lt; 17 years) </content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>29 mg/kg to 60 mg/kg</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>29 mg/kg to 60 mg/kg every 6 hours</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>Initiate at 8 mg/kg/hour to 13 mg/kg/hour</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>
                                       <content styleCode="bold">Adult </content>
                                    </paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>1,000 mg to 2,000 mg</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>1,000 mg to 2,000 mg every 6 hours</paragraph>
                                 </td>
                                 <td styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>Initiate at 5.4 mg/kg/hour to 21.5 mg/kg/hour</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="4" styleCode=" Botrule Toprule Lrule Rrule">
                                    <paragraph>For bolus administration, DO NOT exceed an infusion rate of: </paragraph>
                                    <list listType="unordered" styleCode="Disc">
                                       <item>200 mg/minute in adult patients</item>
                                       <item>100 mg/minute in pediatric patients</item>
                                    </list>
                                    <paragraph>For continuous infusions, adjust rate as needed based on serum calcium levels.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_0649f771-be4c-4444-af7a-a85aae87d185">
                     <id root="ce91116d-80fb-473e-9c16-fe9279e15ddd"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.3 Serum
Calcium Monitoring</title>
                     <text>
                        <paragraph>Measure serum calcium every 4 hours to 6 hours during intermittent infusions with calcium gluconate in sodium chloride injection and measure serum calcium every 1 hour to 4 hours during continuous infusion.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_5b947178-2de6-4700-875d-419d318a2198">
                     <id root="fb28bba5-dfdd-4122-b43a-cef40a9833a1"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.4
Dosage in Renal Impairment</title>
                     <text>
                        <paragraph>For patients with renal impairment, initiate calcium gluconate in sodium chloride injection at the lowest dose of the recommended dose ranges for all age groups and monitor serum calcium levels every 4 hours.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_e464cfe0-f556-4613-9e68-bab58d845931">
                     <id root="7a8377b0-ffb5-452a-9090-4474580dd057"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.5 Drug
Incompatibilities</title>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Do not mix calcium gluconate in sodium chloride injection with ceftriaxone. Concurrent use of intravenous ceftriaxone and calcium gluconate in sodium chloride injection can lead to the formation of ceftriaxone-calcium precipitates. Concomitant use of ceftriaxone and intravenous calcium-containing products is contraindicated in neonates (28 days of age or younger) <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">Contraindications (4)</linkHtml>]</content>. In patients older than 28 days of age, ceftriaxone and calcium-containing products may be administered sequentially, provided the infusion lines are thoroughly flushed between infusions with a compatible fluid. Ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions via a Y-site in any age group <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_daabc1e4-b066-42d3-9c8d-ee7373478eab">Warnings and Precautions (5.2)</linkHtml>, <linkHtml href="#www.splportal.comLINK_9545fca5-23d2-477b-9f5e-2ad77966dcb0">Drug Interactions (7.3)</linkHtml>]. </content>
                           </item>
                           <item>Do not mix calcium gluconate in sodium chloride injection with fluids containing bicarbonate or phosphate. Calcium gluconate injection is not physically compatible with fluids containing phosphate or bicarbonate. Precipitation may result if mixed. </item>
                           <item>Do not mix calcium gluconate in sodium chloride injection with minocycline injection. Calcium complexes minocycline rendering it inactive. </item>
                        </list>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_ed9cc327-a9b2-497e-8154-bd9219fd4770">
               <id root="ac13f97f-565f-453b-a6be-1e34421aa2e2"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>Calcium Gluconate in Sodium Chloride Injection is a clear, colorless solution available in the following: </paragraph>
                  <paragraph>Injection: </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Calcium gluconate 1,000 mg per 50 mL (20 mg per mL) single-dose container. </item>
                     <item>Calcium gluconate 2,000 mg per 100 mL (20 mg per mL) single-dose container. </item>
                  </list>
                  <paragraph>Each mL of calcium gluconate in sodium chloride injection contains 20 mg of calcium gluconate which contains 1.86 mg (0.093 mEq) of elemental calcium. </paragraph>
               </text>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Injection: </paragraph>
                        <list listType="unordered" styleCode="Disk">
                           <item>Single-dose container: 1,000 mg per 50 mL (20 mg per mL)</item>
                           <item>Single-dose container: 2,000 mg per 100 mL (20 mg per mL)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="LINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">
               <id root="ac0c75d6-89fc-42a9-a786-acc4e33c0e46"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Calcium gluconate in sodium chloride injection is contraindicated in: </paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Hypercalcemia </item>
                     <item>Neonates (28 days of age or younger) receiving ceftriaxone <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_daabc1e4-b066-42d3-9c8d-ee7373478eab">Warnings and Precautions (5.2)</linkHtml>] </content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disk">
                           <item>Hypercalcemia (<linkHtml href="#LINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">4</linkHtml>)</item>
                           <item>Neonates (28 days of age or younger) receiving ceftriaxone. (<linkHtml href="#LINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="LINK_4e1684e1-bdaa-4046-ac6f-e2816f5fb48e">
               <id root="a173681b-6593-4aba-ad78-6cfb4ddc2a4c"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS<br/>
               </title>
               <text/>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disk">
                           <item>
                              <content styleCode="italics">Arrhythmias with Concomitant Cardiac Glycoside Use: </content>If concomitant therapy is necessary, calcium gluconate in sodium chloride injection should be given slowly in small amounts and close ECG monitoring is recommended. (<linkHtml href="#LINK_ce7e5595-ee09-40df-947e-9372464c505d">5.1</linkHtml>)</item>
                           <item>
                              <content styleCode="italics">End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates: </content>Concurrent use of intravenous ceftriaxone may cause life-threatening precipitates. Do not administer ceftriaxone simultaneously with calcium gluconate in sodium chloride via a Y-site in any age group. Cases of fatal outcomes in neonates have occurred. (<linkHtml href="#LINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">4</linkHtml>, <linkHtml href="#LINK_daabc1e4-b066-42d3-9c8d-ee7373478eab">5.2</linkHtml>)</item>
                           <item>
                              <content styleCode="italics">Tissue</content>
                              <content styleCode="italics"> Necrosis and Calcinosis: </content>Calcinosis cutis can occur with or without extravasation of calcium gluconate in sodium chloride injection. Tissue necrosis, ulceration and secondary infection are the most serious complications. If extravasation occurs or clinical manifestations of calcinosis cutis are noted, immediately discontinue intravenous administration at that site and treat as needed. (<linkHtml href="#LINK_33dd520c-48cc-4708-a942-e1a6380a77d4">5.3</linkHtml>)</item>
                           <item>
                              <content styleCode="italics">Hypotension, Bradycardia and Cardiac Arrhythmias with Rapid Administration: </content>To avoid adverse reactions that may follow rapid intravenous administration, calcium gluconate in sodium chloride injection should be infused slowly, with careful ECG monitoring for cardiac arrhythmias. (<linkHtml href="#LINK_af37c4d0-ddac-4d03-9bec-a46a4ca7ac2c">5.4</linkHtml>)</item>
                           <item>
                              <content styleCode="italics">Aluminum Toxicity: </content>This product contains aluminum, up to 100 mcg per liter, that may be toxic. (<linkHtml href="#LINK_0b63e27a-4fd5-48a7-843d-d41d35862c91">5.5</linkHtml>)<br/>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="LINK_ce7e5595-ee09-40df-947e-9372464c505d">
                     <id root="b15edb71-5fa7-4be7-8f9b-44a8264357ef"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1
Arrhythmias with Concomitant Cardiac Glycoside Use</title>
                     <text>
                        <paragraph>Cardiac arrhythmias may occur if calcium and cardiac glycosides are administered together. Hypercalcemia increases the risk of digoxin toxicity. Administration of calcium gluconate in sodium chloride injection should be avoided in patients receiving cardiac glycosides. If concomitant therapy is necessary, calcium gluconate in sodium chloride injection should be given slowly in small amounts and with close ECG monitoring <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_9944a35d-e41e-4112-a4a1-2f956a4ce163">Drug Interactions (7.1)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_daabc1e4-b066-42d3-9c8d-ee7373478eab">
                     <id root="34697bb8-e8f9-431e-ba81-339b3ae73dd9"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2
End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates</title>
                     <text>
                        <paragraph>Concomitant use of ceftriaxone and calcium gluconate in sodium chloride injection is contraindicated in neonates (28 days of age or younger) due to cases of fatal outcomes in neonates in which a crystalline material was observed in the lungs and kidneys at autopsy after ceftriaxone and calcium were administrated simultaneously through the same intravenous line. Concomitant administration can lead to the formation of ceftriaxone-calcium precipitates that may act as emboli, resulting in vascular spasm or infarction <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">Contraindications (4)</linkHtml>].</content>
                        </paragraph>
                        <paragraph>In patients older than 28 days of age, ceftriaxone and calcium gluconate in sodium chloride injection may be administered sequentially, provided the infusion lines are thoroughly flushed between infusions with a compatible fluid. Do not administer ceftriaxone simultaneously with calcium gluconate in sodium chloride injection via a Y-site in any age group.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_33dd520c-48cc-4708-a942-e1a6380a77d4">
                     <id root="d6a6e2fe-f0ab-4f75-a62c-21057cc097fc"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3
Tissue Necrosis and Calcinosis</title>
                     <text>
                        <paragraph>Intravenous administration of calcium gluconate in sodium chloride injection and local trauma may result in calcinosis cutis due to transient increase in local calcium concentration. Calcinosis cutis can occur with or without extravasation of calcium gluconate in sodium chloride injection, is characterized by abnormal dermal deposits of calcium salts and clinically manifests as papules, plaques, or nodules that may be associated with erythema, swelling, or induration. Tissue necrosis, ulceration and secondary infection are the most serious complications.</paragraph>
                        <paragraph>If extravasation occurs or clinical manifestations of calcinosis cutis are noted, immediately discontinue intravenous administration at that site and treat as needed. </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_af37c4d0-ddac-4d03-9bec-a46a4ca7ac2c">
                     <id root="128ff799-ae00-4a80-bb80-96c77d5c4589"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4
Hypotension, Bradycardia and Cardiac Arrhythmias with Rapid Administration</title>
                     <text>
                        <paragraph>Rapid injection of calcium gluconate in sodium chloride injection may cause vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmias, syncope and cardiac arrest. To avoid adverse reactions that may follow rapid intravenous administration, calcium gluconate in sodium chloride injection should be infused slowly. If rapid intravenous bolus of calcium gluconate injection is required, the rate of intravenous administration should not exceed 200 mg/minute in adults and 100 mg/minute in pediatric patients and ECG monitoring during administration is recommended <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_3d0f251b-0ddb-43e6-b6e4-7ffc6a03c170">Dosage and Administration (2.1)</linkHtml>]</content>. </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_0b63e27a-4fd5-48a7-843d-d41d35862c91">
                     <id root="9c1f839c-8c03-4185-a238-e83d5518cb3e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5
Aluminum Toxicity</title>
                     <text>
                        <paragraph>Calcium gluconate in sodium chloride injection contains aluminum, up to 100 mcg per liter, that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 mcg/kg/day to 5 mcg/kg/day accumulate aluminum levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_9440e503-baf7-441c-991f-439bc85d32c3">
               <id root="cd43d7e0-2661-4155-bdca-b4a71728b829"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The following serious adverse reactions are also described elsewhere in the labeling:</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Arrhythmias with Concomitant Cardiac Glycoside Use <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_ce7e5595-ee09-40df-947e-9372464c505d">Warnings and Precautions (5.1)</linkHtml>] </content>
                     </item>
                     <item>End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_daabc1e4-b066-42d3-9c8d-ee7373478eab">Warnings and Precautions (5.2)</linkHtml>] </content>
                     </item>
                     <item>Tissue Necrosis and Calcinosis <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_33dd520c-48cc-4708-a942-e1a6380a77d4">Warnings and Precautions (5.3)</linkHtml>]</content>
                     </item>
                     <item>Hypotension, Bradycardia and Cardiac Arrhythmias <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_af37c4d0-ddac-4d03-9bec-a46a4ca7ac2c">Warnings and Precautions (5.4)</linkHtml>] </content>
                     </item>
                     <item>Aluminum toxicity <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_0b63e27a-4fd5-48a7-843d-d41d35862c91">Warnings and Precautions (5.5)</linkHtml>] </content>
                     </item>
                  </list>
                  <paragraph>The following adverse reactions associated with the use of calcium gluconate were identified in the literature. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Cardiovascular</content>
                     </content>: Vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmia, syncope, cardiac arrest.</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">Administration site reactions</content>
                     </content>: Local soft tissue inflammation, local necrosis, calcinosis cutis and calcification due to extravasation.</paragraph>
               </text>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>The most common adverse events with calcium gluconate injection are local soft tissue inflammation and necrosis, calcinosis cutis and calcification that are related to extravasation. Other adverse events include vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmia, syncope and cardiac arrest. (<linkHtml href="#LINK_9440e503-baf7-441c-991f-439bc85d32c3">6</linkHtml>)</paragraph>
                        <paragraph>
                           <content styleCode="bold"> </content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="bold"> </content>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact </content>
                           <content styleCode="bold">Amneal Pharmaceuticals </content>
                           <content styleCode="bold">at </content>
                           <content styleCode="bold">1-877-835-5472</content>
                           <content styleCode="bold"> or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="bold"> </content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="LINK_502b69ea-bc62-44f2-99bf-3b1e2befd8e4">
               <id root="76439a03-07db-4c31-8481-ef3c7082e842"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS</title>
               <text/>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disk">
                           <item>
                              <content styleCode="italics">Cardiac Glycoside</content>: Synergistic arrhythmias may occur if calcium and cardiac glycosides are administered together. (<linkHtml href="#LINK_9944a35d-e41e-4112-a4a1-2f956a4ce163">7.1</linkHtml>)</item>
                           <item>
                              <content styleCode="italics">Calcium Channel Blockers</content>: Administration of calcium may reduce the response. (<linkHtml href="#LINK_419952d9-4f70-41d1-b761-5ba5ab47a9d4">7.2</linkHtml>)</item>
                           <item>
                              <content styleCode="italics">Drugs that may cause hypercalcemia: </content>Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. Monitor plasma calcium concentrations in patients taking these drugs concurrently. (<linkHtml href="#LINK_9545fca5-23d2-477b-9f5e-2ad77966dcb0">7.3</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="LINK_9944a35d-e41e-4112-a4a1-2f956a4ce163">
                     <id root="0201caae-d208-41d7-adb5-d71715eafa28"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.1 Cardiac Glycosides</title>
                     <text>
                        <paragraph>Hypercalcemia increases the risk of digoxin toxicity, while digoxin may be therapeutically ineffective in the presence of hypocalcemia. Synergistic arrhythmias may occur if calcium and cardiac glycosides are administered together. Avoid administration of calcium gluconate in sodium chloride injection in patients receiving cardiac glycosides; if considered necessary, administer calcium gluconate in sodium chloride injection slowly in small amounts and monitor ECG closely during administration.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_419952d9-4f70-41d1-b761-5ba5ab47a9d4">
                     <id root="22e363e6-e4f7-40fc-a0d4-adde69e0b5b3"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.2 Calcium Channel Blockers</title>
                     <text>
                        <paragraph>Administration of calcium may reduce the response to calcium channel blockers.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_9545fca5-23d2-477b-9f5e-2ad77966dcb0">
                     <id root="0e49f453-9bfe-4c32-9484-3937cfb51dee"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.3 Drugs that may cause Hypercalcemia</title>
                     <text>
                        <paragraph>Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. Monitor plasma calcium concentrations in patients taking these drugs concurrently.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_d8fb27d1-edc0-46b8-9cc1-d87f6735066d">
               <id root="2e5a5f92-0041-465c-857e-ca4a7b948fa9"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <text/>
               <effectiveTime value="20240418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="italics">Geriatric use</content>: Dosing in elderly patients should be cautious, usually starting at the low end of the dosage range. (<linkHtml href="#LINK_b4c37d09-7f01-414c-85ef-05a46f5d8c75">8.5</linkHtml>) </item>
                           <item>
                              <content styleCode="italics">Renal impairment: </content>Initiate with the lower limit of the dosage range and monitor serum calcium levels every 4 hours. (<linkHtml href="#LINK_cb470084-ccdc-4be2-9f8f-3ffb88f30739">8.6</linkHtml>, <linkHtml href="#LINK_5b947178-2de6-4700-875d-419d318a2198">2.4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="LINK_e66400c9-2746-49ae-a4d7-425d112a5046">
                     <id root="513b3598-f33d-47c8-8b5e-e44d1667636e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.1 Pregnancy</title>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Risk summary</content>
                        </paragraph>
                        <paragraph>Limited available data with calcium gluconate injection use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. There are risks to the mother and the fetus associated with hypocalcemia in pregnancy <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_e66400c9-2746-49ae-a4d7-425d112a5046">Clinical Considerations</linkHtml>]</content>.</paragraph>
                        <paragraph>The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Clinical Considerations</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Disease-associated maternal risk </content>
                        </paragraph>
                        <paragraph>Maternal hypocalcemia can result in an increased rate of spontaneous abortion, premature and dysfunctional labor and possibly preeclampsia.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Fetal/Neonatal adverse reactions </content>
                        </paragraph>
                        <paragraph>Infants born to mothers with hypocalcemia can have associated fetal and neonatal hyperparathyroidism, which in turn can cause fetal and neonatal skeletal demineralization, subperiosteal bone resorption, osteitis fibrosa cystica and neonatal seizures. Infants born to mothers with hypocalcemia should be carefully monitored for signs of hypocalcemia or hypercalcemia, including neuromuscular irritability, apnea, cyanosis and cardiac rhythm disorders. </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_69427f7a-4af1-454e-9584-c1034574aa4d">
                     <id root="3d2f082f-9125-492d-b9a2-b975ccf1747e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.2
Lactation</title>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Risk summary</content>
                        </paragraph>
                        <paragraph>Calcium is present in human milk as a natural component of human milk. It is not known whether intravenous administration of calcium gluconate in sodium chloride injection can alter calcium concentration in human milk. There are no data on the effects of calcium gluconate injection on the breastfed infant, or on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for calcium gluconate in sodium chloride injection and any potential adverse effects on the breastfed child from calcium gluconate in sodium chloride injection or from the underlying maternal condition. </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_50d458b1-1f28-4f41-9a84-8307b82bc3c8">
                     <id root="0d24f170-74ab-444e-be58-fe5559086ced"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.4
Pediatric Use</title>
                     <text>
                        <paragraph>The safety and effectiveness of calcium gluconate in sodium chloride injection have been established in pediatric patients for the treatment of acute, symptomatic hypocalcemia.</paragraph>
                        <paragraph>Pediatric approval for calcium gluconate in sodium chloride injection, including doses, is not based on adequate and well-controlled clinical studies. Safety and dosing recommendations in pediatric patients are based on published literature and clinical experience <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_5ad6f916-6130-408d-b286-236fc9019e56">Dosage and Administration (2.2)</linkHtml>]</content>.</paragraph>
                        <paragraph>Concomitant use of ceftriaxone and calcium gluconate in sodium chloride injection is contraindicated in neonates (28 days of age or younger) due to reports of fatal outcomes associated with the presence of lung and kidney ceftriaxone-calcium precipitates. In patients older than 28 days of age, ceftriaxone and calcium gluconate injection may be administered sequentially, provided the infusion lines are thoroughly flushed between infusions with a compatible fluid <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_7600ad47-5a2d-4055-b6a8-9334addd62c5">Contraindications (4)</linkHtml> </content>and <content styleCode="italics">
                              <linkHtml href="#www.splportal.comLINK_daabc1e4-b066-42d3-9c8d-ee7373478eab">Warnings and Precautions (5.2)</linkHtml>]</content>. This product contains up to 100 mcg/L aluminum which may be toxic, particularly for premature neonates due to immature renal function. Parenteral administration of aluminum greater than 4 mcg/kg/day to 5 mcg/kg/day is associated with central nervous system and bone toxicity <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_0b63e27a-4fd5-48a7-843d-d41d35862c91">Warnings and Precautions (5.5)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_b4c37d09-7f01-414c-85ef-05a46f5d8c75">
                     <id root="4a78666e-befe-4f48-9a22-4e6e034a78c5"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.5 Geriatric Use</title>
                     <text>
                        <paragraph>In general dose selection for an elderly patient should start at the lowest dose of the recommended dose range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_cb470084-ccdc-4be2-9f8f-3ffb88f30739">
                     <id root="bae9c372-6403-4eb9-9fa0-2a79110de4da"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.6 Renal Impairment</title>
                     <text>
                        <paragraph>For patients with renal impairment, initiate calcium gluconate in sodium chloride injection at the lowest dose of the recommended dose ranges across all age groups. Monitor serum calcium levels every 4 hours <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_5b947178-2de6-4700-875d-419d318a2198">Dosage and Administration (2.4)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_ab8668a7-dd77-4e0d-a165-5e8052f625e6">
                     <id root="cf832348-aa60-43f7-b740-2354e957a933"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.7 Hepatic Impairment</title>
                     <text>
                        <paragraph>Hepatic function does not impact the availability of ionized calcium after calcium gluconate intravenous administration. Dose adjustment in hepatically impaired patients may not be necessary.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_7672321b-456b-49d1-95e6-3b804a643ebe">
               <id root="5286b0f1-d3c7-457f-a378-09d658f1be13"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE</title>
               <text>
                  <paragraph>Overdosage of calcium gluconate in sodium chloride injection may result in hypercalcemia. Symptoms of hypercalcemia typically develop when the total serum calcium concentration is ≥ 12 mg/dL. Neurologic symptoms include depression, weakness, fatigue and confusion at lower levels, with patients experiencing hallucinations, disorientation, hypotonicity, seizures and coma. Effects on the kidney include diminished ability to concentrate urine and diuresis.</paragraph>
                  <paragraph>If overdose of calcium gluconate in sodium chloride injection occurs immediately discontinue administration and provide supportive treatments to restore intravascular volume as well as promote calcium excretion in the urine if necessary.</paragraph>
               </text>
               <effectiveTime value="20240418"/>
            </section>
         </component>
         <component>
            <section ID="LINK_94dfdaa6-3893-42c2-9260-ca4a11462f2f">
               <id root="789d185f-f96e-4443-8e3c-a70f23fde840"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION</title>
               <text>
                  <paragraph>Calcium gluconate in sodium chloride injection is a sterile, clear, colorless, preservative-free, nonpyrogenic, solution of calcium gluconate, a form of calcium, for intravenous use.</paragraph>
                  <paragraph>The chemical name of calcium gluconate monohydrate, USP is calcium D-gluconate (1:2) monohydrate. The structural formula is</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM1"/>
                     <br/>
                  </paragraph>
                  <paragraph>Molecular formula: C<sub>12</sub>H<sub>22</sub>CaO<sub>14</sub>• H<sub>2</sub>O </paragraph>
                  <paragraph>Molecular weight: 448.39 g/mol</paragraph>
                  <paragraph>Solubility in water: 3.5 g/100 mL at 25°C</paragraph>
                  <paragraph>Calcium gluconate monohydrate, USP is a white, crystalline granules or powder. It is soluble in boiling water, sparingly soluble in water and insoluble in alcohol.</paragraph>
                  <paragraph>Calcium Gluconate in Sodium Chloride Injection is available as 1,000 mg per 50 mL (18.8 mg per mL) or 2,000 mg per 100 mL (18.8 mg per mL) filled in single-dose infusion bags.</paragraph>
                  <paragraph>Each mL of calcium gluconate in sodium chloride injection contains 20 mg of calcium gluconate (equivalent to 18.8 mg of calcium gluconate and 0.9 mg of calcium saccharate tetrahydrate), 6.75 mg sodium chloride as tonicity adjustor, hydrochloric acid and/or sodium hydroxide for pH adjustment (6.0 to 8.2) and water for injection.</paragraph>
                  <paragraph>Each mL of calcium gluconate in sodium chloride injection contains 1.86 mg (0.093 mEq) of elemental calcium.</paragraph>
               </text>
               <effectiveTime value="20240418"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>1</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_bccb04cc-3991-4ea2-b6f4-04a6afd0b8f3">
               <id root="8f569657-cb33-48b8-8a7f-340c2dbb05f1"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20240418"/>
               <component>
                  <section ID="LINK_f1abae1d-7871-43d7-bbb1-77ffe4b1ffb5">
                     <id root="cbdcc786-72e6-4c61-b981-7494e0aa20ad"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <paragraph>Intravenous administration of calcium gluconate increases serum ionized calcium level. Calcium gluconate dissociates into ionized calcium in plasma. Ionized calcium and gluconate are normal constituents of body fluids. </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_40da22ab-9880-419c-aac4-3222230c217b">
                     <id root="2353fa17-d414-410c-b482-756492e566f6"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Absorption </content>
                        </paragraph>
                        <paragraph>Calcium gluconate injection is 100% bioavailable following intravenous injection.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Metabolism </content>
                        </paragraph>
                        <paragraph>Calcium itself does not undergo direct metabolism. The release of ionized calcium from intravenous administration of calcium gluconate is direct and does not seem to be affected by the first pass through the liver.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Distribution </content>
                        </paragraph>
                        <paragraph>Calcium in the body is distributed mainly in skeleton (99%). Only 1% of the total body calcium is distributed within the extracellular fluids and soft tissues. About 50% of total serum calcium is in the ionized form and represents the biologically active part. 8% to 10% serum calcium is bound to organic and inorganic acid and approximately 40% is protein-bound (primarily to albumin).</paragraph>
                        <paragraph>
                           <content styleCode="underline">Elimination </content>
                        </paragraph>
                        <paragraph>Studies have shown a relationship between urinary calcium excretion and the intravenous administration of calcium gluconate, with a significant increase in urinary calcium excretion observed after the intravenous administration of calcium gluconate. </paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_5daa79e6-a212-4003-bec5-c4661f04ac51">
               <id root="a45668ff-e71c-459b-9c5b-32b2a35b2488"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <effectiveTime value="20240418"/>
               <component>
                  <section ID="LINK_de7b6a6c-102a-443a-8563-e9fb72cae2d9">
                     <id root="88bde719-647b-470d-a32b-c9e9007d99e4"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>Long-term studies in animals have not been conducted to evaluate the carcinogenic potential of calcium gluconate in sodium chloride injection. Calcium gluconate was not mutagenic with or without metabolic activation in the Ames test with <content styleCode="italics">Salmonella typhimurium </content>(strains TA-1535, TA-1537 and TA-1538) or <content styleCode="italics">Saccharomyces cerevisiae </content>(Strain D4). Fertility studies in animals have not been conducted with calcium gluconate administered by the intravenous route.</paragraph>
                     </text>
                     <effectiveTime value="20240418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_a0b45d85-af35-4ea1-b85b-0827eb4c813b">
               <id root="31b27f27-c283-4352-938b-e6d2aae75c9f"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
               <text>
                  <paragraph>Calcium Gluconate in Sodium Chloride Injection is a clear, colorless solution supplied as follows:</paragraph>
                  <table width="100%" cellspacing="0" cellpadding="0" border="1">
                     <col width="17%"/>
                     <col width="17%"/>
                     <col width="17%"/>
                     <tbody>
                        <tr>
                           <td styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>
                                 <content styleCode="bold">Strength</content>
                              </paragraph>
                           </td>
                           <td styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>
                                 <content styleCode="bold">Each</content>
                              </paragraph>
                           </td>
                           <td styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>
                                 <content styleCode="bold">Unit of Sale</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td rowspan="2" styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>1,000 mg per 50 mL </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(20 mg per mL)</content>
                              </paragraph>
                           </td>
                           <td rowspan="2" styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>NDC 80830-2362-1</paragraph>
                              <paragraph>1 Single-dose Intravenous Bag in an Overwrap</paragraph>
                           </td>
                           <td styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>NDC 80830-2362-9</paragraph>
                              <paragraph>Unit of 24</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> 
            <paragraph>NDC 80830-2362-2</paragraph>
            Unit of 12</td>
                        </tr>
                        <tr>
                           <td rowspan="2" styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>2,000 mg per 100 mL </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(20 mg per mL)</content>
                              </paragraph>
                           </td>
                           <td rowspan="2" styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>NDC 80830-2363-1</paragraph>
                              <paragraph>1 Single-dose Intravenous Bag in an Overwrap</paragraph>
                           </td>
                           <td styleCode=" Botrule Toprule Lrule Rrule">
                              <paragraph>NDC 80830-2363-9</paragraph>
                              <paragraph>Unit of 24</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" styleCode=" Botrule Toprule Lrule Rrule"> 
            <paragraph>NDC 80830-2363-2</paragraph>
            Unit of 12</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>The container closure is not made with natural rubber latex. Non-PVC, Non-DEHP, Sterile.</paragraph>
                  <paragraph>Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Product should be used within 60 days of removal from overwrap.</paragraph>
                  <paragraph>Preservative Free. Discard any unused portion in the single-dose container immediately.</paragraph>
               </text>
               <effectiveTime value="20240418"/>
            </section>
         </component>
         <component>
            <section ID="LINK_7f1499bb-6eb0-433e-ad99-1e4cdeab02da">
               <id root="a04c72f1-e8f9-4439-b9d1-d5fdb3844cc7"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION</title>
               <text>
                  <list listType="unordered" styleCode="Disc">
                     <item>Advise the patient of the risks associated with infusion of calcium gluconate in sodium chloride injection including local tissue inflammation, local necrosis and calcinosis <content styleCode="italics">[see <linkHtml href="#www.splportal.comLINK_33dd520c-48cc-4708-a942-e1a6380a77d4">Warnings and Precautions (5.3)</linkHtml>]</content>.</item>
                  </list>
                  <paragraph>Manufactured by:</paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals Pvt. Ltd.</content>
                  </paragraph>
                  <paragraph> Ahmedabad 382110, INDIA                                                                                                            </paragraph>
                  <paragraph>Distributed by: </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC </content>
                  </paragraph>
                  <paragraph>Bridgewater, NJ 08807</paragraph>
                  <paragraph>Rev. 04-2024-02</paragraph>
               </text>
               <effectiveTime value="20240418"/>
            </section>
         </component>
         <component>
            <section ID="LINK_3d87df18-2dda-4d16-b4be-ede5d6584ea0">
               <id root="26ae105f-07b1-4c70-ba61-f5e794702e48"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">NDC 80830-2362-1</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Calcium Gluconate in Sodium Chloride Injection, 20 mg/mL (1,000 mg/50 mL)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Intravenous Bag Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="MM2"/>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 80830-2362-1</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Calcium Gluconate in Sodium Chloride Injection, 20 mg/mL (1,000 mg/50 mL)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Pouch Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM3">
                     <caption>Pouch label 1g</caption>
                  </renderMultiMedia>
                  <paragraph>
                     <content styleCode="bold">NDC 80830-2362-9</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Calcium Gluconate in Sodium Chloride Injection, 20 mg/mL (1,000 mg/50 mL)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">24 x 50 mL Carton Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="MM4"/>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 80830-2363-1</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Calcium Gluconate in Sodium Chloride Injection, 20 mg/mL (2,000 mg/100 mL)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Intravenous Bag Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM5"/>
                  <paragraph>
                     <content styleCode="bold">NDC 80830-2363-1</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Calcium Gluconate in Sodium Chloride Injection, 20 mg/mL (2,000 mg/100 mL)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Pouch Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="MM6">
                           <caption>Pouch label 2g</caption>
                        </renderMultiMedia>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 80830-2363-9</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Calcium Gluconate in Sodium Chloride Injection, 20 mg/mL (2,000 mg/100 mL)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">24 x 100 mL Carton Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Amneal Pharmaceuticals LLC</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="MM7"/>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20240418"/>
               <component>
                  <observationMedia ID="MM2">
                     <text>1 g</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM3">
                     <text>Pouch label 1g</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM4">
                     <text>1</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM5">
                     <text>2 g</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-5.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM6">
                     <text>Pouch label 2g</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-6.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM7">
                     <text>1</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="calcium-gluconate-in-sodium-chloride-injection-7.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>